GB Sciences, Inc. (GBLX)
OTCMKTS · Delayed Price · Currency is USD
0.0003
-0.0001 (-25.00%)
Feb 12, 2026, 9:30 AM EST
GB Sciences Market Cap
GB Sciences has a market cap or net worth of $153.72 thousand as of February 13, 2026. Its market cap has decreased by -89.51% in one year.
Market Cap
153.72K
Enterprise Value
2.15M
Revenue
97.24K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since March 19, 2014, GB Sciences's market cap has decreased from 2.53M to 153.72K, a decrease of -93.93%. That is a compound annual growth rate of -20.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 12, 2026 | 153.72K | -40.00% |
| Dec 31, 2025 | 256.20K | -84.27% |
| Dec 31, 2024 | 1.63M | -36.83% |
| Dec 29, 2023 | 2.58M | -61.28% |
| Dec 30, 2022 | 6.66M | 2.29% |
| Dec 31, 2021 | 6.51M | -44.95% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Hepion Pharmaceuticals | 429.95K |
| Actavia Life Sciences | 385.91K |
| Ocean Biomedical | 371.78K |
| THC Farmaceuticals | 362.63K |
| Regen BioPharma | 353.67K |
| Windtree Therapeutics | 343.37K |
| Endonovo Therapeutics | 180.76K |
| CNBX Pharmaceuticals | 168.87K |